Table 2.

World reports of rapidly growing mycobacteria isolated from the central nervous system after insertion of VP shunt

Authors	Country	Age/Sex	Underlying disease	Mode of acquisition	Mycobacterium spp	Treatment	Duration of therapy	Outcome
Chan et al 6	Hong Kong	60 years/female	Cerebral haemorrhage	VA shunt	M. fortuitum	Intravenous amikacin, ofloxacin	2.5 months	Alive
Midani and Rathore5	USA	13 years/female	Spina bifida	VP shunt	M. fortuitum	Intravenous amikacin, cotrimoxazole	7.5 months	Alive
Viswanathan et al 7	India	60 years/male	Traumatic brain injury	Ventriculoarterial shunt	M. fortuitum	Intravenous kanamycin, ciprofloxacin	6 months	Alive
Cadena et al 4	USA	14 years/male	Congenital hydrocephalus	VP shunt	M. fortuitum	Intravenous meropenem, oral cotrimoxazole, oral moxifloxacin		Alive
Baidya et al 3	India	59 years/male	Tubercular meningitis/hydrocephalus	VP shunt	M. abscessus	Intravenous amikacin, clarithromycin, meropenem, shunt removal	1 week	Died
Montero et al 2	USA	30 years/male	Hydrocephalus	VP shunt	M. abscessus	Intravenous azithromycin, imipenem, amikacin, shunt removal	2 years	Alive
Present case	India	14 years/female	Glioma/Hydrocephalus	VP shunt	M. fortuitum	Intravenous linezolid, ofloxacin, clofazimine, clarithromycin	Continuing	Alive

VA, ventriculoatrial; VP, ventriculoperitoneal.